|
WO2000069810A1
(en)
|
1999-05-17 |
2000-11-23 |
Novo Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
US6645980B1
(en)
|
2000-05-25 |
2003-11-11 |
Sepracor Inc. |
Heterocyclic analgesic compounds and methods of use thereof
|
|
JP2003500392A
(ja)
|
1999-05-25 |
2003-01-07 |
セプラコール， インク． |
複素環式鎮痛性化合物およびその使用方法
|
|
US6511980B2
(en)
|
2000-05-05 |
2003-01-28 |
Ortho Mcneil Pharmaceutical, Inc. |
Substituted diamine derivatives useful as motilin antagonists
|
|
IL154363A0
(en)
|
2000-09-25 |
2003-09-17 |
Actelion Pharmaceuticals Ltd |
Substituted amino-aza-cycloalkanes useful against malaria
|
|
FR2815032B1
(fr)
|
2000-10-10 |
2003-08-08 |
Pf Medicament |
Nouveaux derives d'aminophenyle piperazine ou d'amino phenyle piperide inhibiteurs de proteines prenyl transferase ainsi que leurs preparations
|
|
FR2825706B1
(fr)
|
2001-06-06 |
2003-12-12 |
Pf Medicament |
Nouveaux derives de benzothienyle ou d'indole, leur preparation et leur utilisation comme inhibiteurs de proteines prenyl transferase
|
|
FR2839974B1
(fr)
|
2002-05-24 |
2004-07-16 |
Pf Medicament |
Derives de phenyl-furane ou de phenyl-thiophene,leur preparation et leur application a titre de medicament
|
|
AU2003249983A1
(en)
|
2002-07-18 |
2004-02-09 |
Actelion Pharmaceuticals Ltd |
Piperidines useful for the treatment of central nervous system disorders
|
|
BR0314126A
(pt)
|
2002-09-20 |
2005-06-28 |
Pfizer Prod Inc |
Ligandos de amida acìclica e sulfonamida para o receptor de estrogênio
|
|
WO2004046162A2
(en)
|
2002-11-14 |
2004-06-03 |
The Scripps Research Institute |
Non-steroidal fxr agonists
|
|
US7647217B2
(en)
|
2002-11-15 |
2010-01-12 |
The Salk Institute For Biological Studies |
Structure of the farnesoid X receptor ligand binding domain and methods of use therefor
|
|
US20050143449A1
(en)
|
2002-11-15 |
2005-06-30 |
The Salk Institute For Biological Studies |
Non-steroidal farnesoid X receptor modulators and methods for the use thereof
|
|
GB0309781D0
(en)
|
2003-04-29 |
2003-06-04 |
Glaxo Group Ltd |
Compounds
|
|
US7759348B2
(en)
|
2003-07-30 |
2010-07-20 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives and their use as therapeutic agents
|
|
EP1648874B1
(en)
|
2003-07-30 |
2011-10-05 |
Xenon Pharmaceuticals Inc. |
Piperazine derivatives and their use as therapeutic agents
|
|
US7754711B2
(en)
|
2003-07-30 |
2010-07-13 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives and their use as therapeutic agents
|
|
WO2005058822A1
(en)
|
2003-12-17 |
2005-06-30 |
Actelion Pharmaceuticals Ltd |
Substituted amino-cycloalkanes
|
|
CN1914205A
(zh)
|
2003-12-19 |
2007-02-14 |
葛兰素集团有限公司 |
吡唑并[3,4－b]吡啶化合物及其作为磷酸二酯酶抑制剂的用途
|
|
PL1734970T3
(pl)
|
2004-03-12 |
2015-05-29 |
Intercept Pharmaceuticals Inc |
Leczenie zwłóknienia z zastosowaniem ligandów FXR
|
|
WO2005097760A1
(en)
|
2004-03-26 |
2005-10-20 |
Rigel Pharmaceuticals, Inc. |
Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses
|
|
WO2005113522A1
(en)
|
2004-05-07 |
2005-12-01 |
Janssen Pharmaceutica, N.V. |
Azole carboxamide inhibitors of bacterial type iii protein secretion systems
|
|
JP2006199656A
(ja)
|
2005-01-24 |
2006-08-03 |
Kowa Co |
アミド基を有する環状アミン化合物
|
|
MY144229A
(en)
|
2006-01-26 |
2011-08-15 |
Xenon Pharmaceuticals Inc |
Pyridazine derivatives and their use as therapeutic agents
|
|
CN101395170A
(zh)
|
2006-02-14 |
2009-03-25 |
英特塞普特药品公司 |
用于预防或治疗fxr介导的疾病或状态的作为fxr配体的胆汁酸衍生物
|
|
EP2001851A2
(en)
|
2006-03-28 |
2008-12-17 |
Novartis AG |
Amide derivatives and their application for the treament of g protein related diseases
|
|
US20080081824A1
(en)
|
2006-09-29 |
2008-04-03 |
Bristol-Myers Squibb Company |
Substituted piperidines as modulators of chemokine receptor activity
|
|
WO2008065500A2
(en)
|
2006-11-30 |
2008-06-05 |
Pfizer Products Inc. |
Heteroaryl amides as type i glycine transport inhibitors
|
|
EP2234977A4
(en)
|
2007-12-19 |
2011-04-13 |
Boehringer Ingelheim Int |
VIRAL POLYMERASE INHIBITORS
|
|
US20090270418A1
(en)
|
2008-01-09 |
2009-10-29 |
Marianne Sloss |
Pyrazole pyrazine amine compounds as kinase inhibitors, compositions thereof and methods of treatment therewith
|
|
US20100029657A1
(en)
|
2008-02-29 |
2010-02-04 |
Wyeth |
Bridged, Bicyclic Heterocyclic or Spiro Bicyclic Heterocyclic Derivatives of Pyrazolo[1, 5-A]Pyrimidines, Methods for Preparation and Uses Thereof
|
|
WO2010001869A1
(ja)
|
2008-06-30 |
2010-01-07 |
武田薬品工業株式会社 |
４置換ベンゼン化合物およびその用途
|
|
JP2010077109A
(ja)
|
2008-08-28 |
2010-04-08 |
Takeda Chem Ind Ltd |
複素環化合物およびその用途
|
|
JP2012516885A
(ja)
|
2009-02-04 |
2012-07-26 |
ファイザー・インク |
４−アミノ−７，８−ジヒドロピリド［４，３−ｄ］ピリミジン−５（６Ｈ）−オン誘導体
|
|
CA2767089A1
(en)
|
2009-07-15 |
2011-01-20 |
Abbott Laboratories |
Pyrrolopyridine inhibitors of kinases
|
|
EP2454243A2
(en)
|
2009-07-15 |
2012-05-23 |
Merck Serono SA |
Tetrazole derivatives
|
|
FR2963005B1
(fr)
|
2010-07-23 |
2012-08-17 |
Sanofi Aventis |
Derives d'oxadiazoles et de pyridazines, leur preparation et leur application en therapeutique
|
|
WO2012087521A1
(en)
|
2010-12-20 |
2012-06-28 |
Irm Llc |
Compositions and methods for modulating farnesoid x receptors
|
|
KR101834362B1
(ko)
|
2011-03-18 |
2018-03-05 |
바이엘 인텔렉쳐 프로퍼티 게엠베하 |
N-(3-카바모일페닐)-1h-피라졸-5-카복사미드 유도체 및 동물 해충을 구제하기 위한 그의 용도
|
|
ME02754B
(me)
|
2011-03-23 |
2018-01-20 |
Trevena Inc |
Ligandi opioidnih receptora i postupci njihove upotrebe i pripreme
|
|
EP2545964A1
(en)
|
2011-07-13 |
2013-01-16 |
Phenex Pharmaceuticals AG |
Novel FXR (NR1H4) binding and activity modulating compounds
|
|
EP2732871A4
(en)
|
2011-07-13 |
2015-03-04 |
M Tech Co Ltd |
PROCESS FOR PRODUCING MICROPARTICLES WITH CONTROLLED CRYSTALLITE DIAMETER
|
|
WO2013037482A1
(en)
|
2011-09-15 |
2013-03-21 |
Phenex Pharmaceuticals Ag |
Farnesoid x receptor agonists for cancer treatment and prevention
|
|
RU2543485C2
(ru)
|
2013-02-26 |
2015-03-10 |
Андрей Александрович Иващенко |
Гетероциклические агонисты рецепторов желчных кислот tgr5, фармацевтическая композиция, способы их получения и применения
|
|
DK3043865T3
(da)
|
2013-09-11 |
2021-02-01 |
Univ Claude Bernard Lyon |
Fremgangsmåder og farmaceutiske sammensætningr til behandlingen af hepatitis b-virusinfektion
|
|
GB201316824D0
(en)
|
2013-09-23 |
2013-11-06 |
R & D Vernalis Ltd |
New Chemical Entities
|
|
US20150258052A1
(en)
|
2014-03-13 |
2015-09-17 |
Salk Institute For Biological Studies |
Methods of using fexaramine and agents that increase sympathetic nervous system activity to promote browning of white adipose tissue
|
|
KR20160132111A
(ko)
|
2014-03-13 |
2016-11-16 |
더 솔크 인스티튜트 포 바이올로지칼 스터디즈 |
Fxr 작용제와 제조방법 및 용도
|
|
US10301268B2
(en)
|
2014-03-13 |
2019-05-28 |
The Salk Institute For Biological Studies |
Analogs of fexaramine and methods of making and using
|
|
US10077268B2
(en)
|
2014-03-13 |
2018-09-18 |
Salk Institute For Biological Studies |
FXR agonists and methods for making and using
|
|
EP3116851B1
(en)
|
2014-03-13 |
2023-07-26 |
Salk Institute for Biological Studies |
Analogs of fexaramine and methods of making and using
|
|
US20180116993A1
(en)
|
2015-01-22 |
2018-05-03 |
Xiamen University |
Modulators of farnesoid x receptor and methods for the use thereof
|
|
AU2016233579A1
(en)
|
2015-03-13 |
2017-10-12 |
Salk Institute For Biological Studies |
Treating latent autoimmune diabetes of adults with farnesoid X receptor agonists to activate intestinal receptors
|
|
WO2017018751A1
(ko)
|
2015-07-24 |
2017-02-02 |
동국대학교 산학협력단 |
Blt 저해 활성을 갖는 신규 화합물 및 이를 유효성분으로 포함하는 염증성 질환 예방 또는 치료용 조성물
|
|
US10703712B2
(en)
|
2015-09-16 |
2020-07-07 |
Metacrine, Inc. |
Farnesoid X receptor agonists and uses thereof
|
|
US10626081B2
(en)
|
2015-09-16 |
2020-04-21 |
Metacrine, Inc. |
Farnesoid X receptor agonists and uses thereof
|
|
EP3350164A4
(en)
|
2015-09-16 |
2019-03-27 |
Metacrine, Inc. |
FARNESOID-X RECEPTOR AGONISTS AND USES THEREOF
|
|
WO2017049177A1
(en)
|
2015-09-16 |
2017-03-23 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
MX389514B
(es)
|
2015-10-01 |
2025-03-20 |
Firmenich Incorporated |
Compuestos útiles como moduladores de canal receptor 8 de potencial transitorio de melastatina (trpm8).
|
|
CN105477636B
(zh)
|
2015-10-16 |
2019-09-17 |
厦门大学 |
使用阿维菌素及其衍生物治疗代谢疾病的方法
|
|
WO2017078928A1
(en)
|
2015-11-06 |
2017-05-11 |
Salk Institute For Biological Studies |
Fxr agonists and methods for making and using
|
|
CN107126419B
(zh)
|
2016-02-26 |
2020-06-19 |
石药集团中诺药业（石家庄）有限公司 |
一种奥贝胆酸片剂及其制备方法
|
|
WO2017170182A1
(ja)
|
2016-03-31 |
2017-10-05 |
株式会社Adeka |
感光性組成物及び新規化合物
|
|
WO2018170165A1
(en)
|
2017-03-15 |
2018-09-20 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
JP7258763B2
(ja)
*
|
2017-03-15 |
2023-04-17 |
メタクリン，インク． |
ファルネソイドｘ受容体アゴニストおよびその使用
|
|
US20200131129A1
(en)
|
2017-03-15 |
2020-04-30 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
CA3055990A1
(en)
*
|
2017-03-15 |
2018-09-20 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
WO2018170167A1
(en)
|
2017-03-15 |
2018-09-20 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
CZ2017298A3
(cs)
|
2017-05-26 |
2018-12-05 |
Zentiva, K.S. |
Amorfní formy obeticholové kyseliny
|
|
WO2020060007A1
(ko)
|
2018-09-17 |
2020-03-26 |
엘지전자 주식회사 |
5g 이동통신에서 pdu 세션을 핸들링하는 방법 및 무선 기기
|
|
JP2022500393A
(ja)
*
|
2018-09-18 |
2022-01-04 |
メタクリン，インク． |
ファルネソイドｘ受容体アゴニストおよびその使用
|
|
WO2020061118A1
(en)
|
2018-09-18 |
2020-03-26 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
EP3852749A4
(en)
|
2018-09-18 |
2022-08-24 |
Metacrine, Inc. |
CRYSTALLINE FORMS OF A FARNESOID X RECEPTOR AGONIST
|
|
WO2020061116A1
(en)
*
|
2018-09-18 |
2020-03-26 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
EA202190661A1
(ru)
|
2018-09-18 |
2021-08-13 |
Метакрайн, Инк. |
Агонисты фарнезоидного х-рецептора для лечения заболевания
|
|
CN113056264A
(zh)
|
2018-09-18 |
2021-06-29 |
梅塔科林公司 |
法尼醇x受体激动剂及其用途
|
|
AU2019344903B2
(en)
|
2018-09-18 |
2025-02-27 |
Eli Lilly And Company |
Farnesoid X receptor agonists and uses thereof
|
|
CN120732855A
(zh)
|
2020-03-18 |
2025-10-03 |
伊莱利利公司 |
用于治疗疾病的法尼醇x受体激动剂
|
|
KR20220155356A
(ko)
|
2020-03-18 |
2022-11-22 |
메타크린, 인크. |
파르네소이드 x 수용체 효능제의 결정형
|
|
WO2021188695A1
(en)
|
2020-03-18 |
2021-09-23 |
Metacrine, Inc. |
Formulations of a farnesoid x receptor agonist
|